Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Heart Rhythm ; 11(12): 2176-82, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25034184

RESUMO

BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become the standard therapy for high-risk and non-operable patients with severe aortic stenosis. However, the procedure involves several adverse effects, such as rhythm and conduction disturbances. Patients with postprocedural left bundle branch block may have an increased mortality risk, whereas patients with preprocedural right bundle branch block display a higher rate of postinterventional bradyarrhythmias. OBJECTIVE: The purpose of this study was to investigate the occurrence of high-degree atrioventricular block (AVB) in patients with preexisting bundle branch block (BBB) or BBB occurring during TAVI. METHODS: In this prospective single-center study, 50 consecutive patients undergoing TAVI with the Medtronic CoreValve Revalving System were included. Of these patients, 17 with preexisting BBB or BBB occurring during TAVI received a primary prophylactic permanent DDD pacemaker, programmed to the SafeR-mode and featuring dual-channel event counters as well as stored intracardiac electrograms. Pacemaker readouts and intracardiac electrograms were analyzed for the occurrence of high-degree AVB. RESULTS: Ten of 17 patients (58.8%) with preexisting BBB or BBB occurring during TAVI developed episodes of high-degree AVB that were immediately terminated due to switch into DDD backup pacing. In 5 of the cases (29.4%), the first documented episode of high-degree AVB occurred after hospital discharge. Mean follow-up period was 578.1 ± 294.9 days. CONCLUSION: Development of high-degree AVB is a common complication in patients with preexisting BBB or BBB occurring during TAVI. Accordingly, intensified monitoring might be reasonable, especially in patients treated with the self-expandable Medtronic CoreValve Revalving System.


Assuntos
Estenose da Valva Aórtica/cirurgia , Bloqueio Atrioventricular/epidemiologia , Bloqueio de Ramo/epidemiologia , Complicações Intraoperatórias/epidemiologia , Substituição da Valva Aórtica Transcateter/efeitos adversos , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Animais , Estenose da Valva Aórtica/diagnóstico por imagem , Estenose da Valva Aórtica/mortalidade , Bloqueio Atrioventricular/diagnóstico , Bloqueio Atrioventricular/terapia , Bloqueio de Ramo/diagnóstico , Bloqueio de Ramo/terapia , Estudos de Coortes , Eletrocardiografia/métodos , Feminino , Seguimentos , Humanos , Incidência , Complicações Intraoperatórias/diagnóstico , Masculino , Marca-Passo Artificial , Cobertura de Condição Pré-Existente , Estudos Prospectivos , Índice de Gravidade de Doença , Distribuição por Sexo , Estatísticas não Paramétricas , Análise de Sobrevida , Substituição da Valva Aórtica Transcateter/métodos , Resultado do Tratamento , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA